Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arne Christians

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Acta Neuropathologica Communications|October 19, 2019
The prognostic role of IDH mutations in homogeneously treated patients with anaplastic astrocytomas and glioblastomasArne Christians, Antonia Adel-Horowski, Rouzbeh Banan, et al.
Cell Reports Methods|April 27, 2022
Multiplexed imaging and automated signal quantification in formalin-fixed paraffin-embedded tissues by ChipCytometrySebastian Jarosch, Jan Köhlen, Rim S J Sarker, et al.
Journal of Neuro-Oncology|April 25, 2012
No prognostic value of IDH1 mutations in a series of 100 WHO grade II astrocytomasRezvan Ahmadi, Florian Stockhammer, Natalia Becker, et al.
Acta Neuropathologica Communications|November 8, 2023
EMP3 sustains oncogenic EGFR/CDK2 signaling by restricting receptor degradation in glioblastomaAntoni Andreu Martija, Alexandra Krauß, Natalie Bächle, et al.
European Journal of Human Genetics : EJHG|August 2, 2020
Rare heterozygous GDF6 variants in patients with renal anomaliesHelge Martens, Imke Hennies, Maike Getwan, et al.
Acta Neuropathologica|June 26, 2009
Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomasChristian Hartmann, Jochen Meyer, Jörg Balss, et al.
Acta Neuropathologica|October 15, 2017
Rare ADAR and RNASEH2B variants and a type I interferon signature in glioma and prostate carcinoma risk and tumorigenesisUlrike Beyer, Frank Brand, Helge Martens, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Acta Neuropathologica Communications|October 19, 2019
The prognostic role of IDH mutations in homogeneously treated patients with anaplastic astrocytomas and glioblastomasArne Christians, Antonia Adel-Horowski, Rouzbeh Banan, et al.
Cell Reports Methods|April 27, 2022
Multiplexed imaging and automated signal quantification in formalin-fixed paraffin-embedded tissues by ChipCytometrySebastian Jarosch, Jan Köhlen, Rim S J Sarker, et al.
Journal of Neuro-Oncology|April 25, 2012
No prognostic value of IDH1 mutations in a series of 100 WHO grade II astrocytomasRezvan Ahmadi, Florian Stockhammer, Natalia Becker, et al.
Acta Neuropathologica Communications|November 8, 2023
EMP3 sustains oncogenic EGFR/CDK2 signaling by restricting receptor degradation in glioblastomaAntoni Andreu Martija, Alexandra Krauß, Natalie Bächle, et al.
European Journal of Human Genetics : EJHG|August 2, 2020
Rare heterozygous GDF6 variants in patients with renal anomaliesHelge Martens, Imke Hennies, Maike Getwan, et al.
Acta Neuropathologica|June 26, 2009
Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomasChristian Hartmann, Jochen Meyer, Jörg Balss, et al.
Acta Neuropathologica|October 15, 2017
Rare ADAR and RNASEH2B variants and a type I interferon signature in glioma and prostate carcinoma risk and tumorigenesisUlrike Beyer, Frank Brand, Helge Martens, et al.
Pageof 2